COMPARE - RESULTS OF A RANDOMISED STUDY TO ASSESS THE RENAL SAFETY AND EFFICACY OF IBANDRONATE AND ZOLEDRONATE IN MULTIPLE MYELOMA PATIENTS

被引：0
|
作者：
Knauf, U. [1 ]
Bergner, R. [2 ]
Kropff, M. [2 ]
Poenisch, W. [3 ]
Kiewitz, C. [4 ]
Goldschmidts, H. [5 ]
机构：
[1] Onkol Gemeinschaftspraxis, Frankfurt, Germany
[2] Med Klin A, Ludwigshafen, Germany
[3] Med Klin 2, Leipzig, Germany
[4] Roche Pharma AG, Grenzach Wyhlen, Germany
[5] Med Klin 5, Heidelberg, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0961
引用
收藏
页码：398 / 398
页数：1
相关论文
共 50 条
  • [1] COMPARE - Results of a randomised study to assess the renal safety and efficacy of ibandronate and zoledronate in multiple myeloma patients
    Knauf, W.
    Bergner, R.
    Kropff, M.
    Poenisch, W.
    Kiewitz, C.
    Goldschmidt, H.
    ONKOLOGIE, 2010, 33 : 246 - 246
  • [2] COMPARE - Results of a randomised study to assess the renal safety and efficacy of ibandronate and zoledronate in multiple myeloma patients
    Bergner, Raoul
    Goldschmidt, Hartmut
    Kropff, Martin
    Poenisch, Wolfram
    Kiewitz, Claudia
    Knauf, Wolfgang
    BONE, 2010, 46 : S34 - S35
  • [3] Renal safety of ibandronate in multiple myeloma patients with renal deterioration
    Bergner, R
    Henrich, DM
    Hoffmann, M
    Ullmann, M
    Honecker, A
    Nagel, D
    Uppenkamp, M
    CANCER TREATMENT REVIEWS, 2005, 31 : S45 - S45
  • [4] Renal safety of ibandronate in patients with renal deterioration and multiple myeloma
    Raoul, R
    Henrich, DM
    Hoffmann, M
    Ullmann, M
    Honecker, A
    Nagel, D
    Uppenkamp, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V100 - V101
  • [5] The compare study - An assessment of renal toxicity of ibandronate and zoledronic acid in multiple myeloma patients
    Knauf, Wolfgang
    Gaede, Bernd
    Bergner, Raoul
    Ziegler, Johannes
    BONE, 2008, 42 : S98 - S98
  • [6] Renal safety of ibandronate in patients with relapsed and refractory multiple myeloma
    Glasmacher, A
    Hoffmann, F
    Orlopp, K
    von Lilienfeld-Toal, M
    Hahn, C
    BONE, 2006, 38 (03) : S73 - S73
  • [7] Renal safety of ibandronate in the treatment of myeloma patients
    Breuer, J.
    Uppenkamp, M.
    Sandermann, A.
    Hoffmann, M.
    Bergner, R.
    ONKOLOGIE, 2010, 33 : 157 - 157
  • [8] Renal safety of ibandronate in the treatment of myeloma patients
    Bergner, Raoul
    Jochen, Breuer
    Uppenkamp, Michael
    Sandermann, Andreas
    Hoffmann, Martin
    BONE, 2010, 46 : S35 - S35
  • [9] Renal safety and pharmacokinetics of ibandronate in multiple myeloma patients with or without impaired renal function
    Bergner, Raoul
    Henrich, Dirk M.
    Hoffmann, Martin
    Honecker, Andrea
    Mikus, Gerd
    Nauth, Bettina
    Nagel, Dietmar
    Uppenkamp, Michael
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (08): : 942 - 950
  • [10] Renal safety and pharmacokinetics of ibandronate in multiple myeloma patients with pre-existing renal insufficiency
    Bergner, R.
    Nauth, B.
    Henrich, D. M.
    Hoffmann, M.
    Ullmann, M.
    Honecker, A.
    Nagel, D.
    Uppenkamp, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 206 - 206
12345